Protection against 7,12-dimethylbenzanthracene-induced tumour initiation by protein A in mouse skin

Protein A is an immunostimulating glycoprotein obtained from Staphylococcus aureus Cowan I. Its antitumour activity is proven in various tumour models. Its ability to provide protection against tumour initiation by the chemical carcinogen 7,12-dimethylbenzanthracene (DMBA) has been investigated in t...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 61; no. 2; pp. 105 - 110
Main Authors Kumar, Sushil, Shukla, Yogeshwer, Prasad, Arun Kumar, Verma, A.S., Dwivedi, P.D., Mehrotra, N.K., Ray, P.K.
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 10.01.1992
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Protein A is an immunostimulating glycoprotein obtained from Staphylococcus aureus Cowan I. Its antitumour activity is proven in various tumour models. Its ability to provide protection against tumour initiation by the chemical carcinogen 7,12-dimethylbenzanthracene (DMBA) has been investigated in the present study using a mouse skin model of two-stage carcinogenesis. Protein A was administered intraperitoneally (l μg/animal 20 g body wt.) twice a week for 2 weeks, prior to initiation by DMBA. The promotion was performed by twice weekly applications of 12-O-tetradecanoyl phorbol-13-acetate (TPA) (3 or 5 μg/animal in 100 μl acetone). Protein A provided significant protection animals from DMBA-induced tumour initiation as was observed by the decrease in cumulative number of tumours, percent of animals developing tumours, number of tumours per animal and rate of tumour growth. Our data indicate that protein A has anticarcinogenic properties.
ISSN:0304-3835
1872-7980
DOI:10.1016/0304-3835(92)90167-T